4-NITROBENZYL (R)-2-DIAZO-4-((2R,3S)-3-((R)-1-HYDROXYETHYL)-4-OXOAZETIDIN-2-YL)-3-OXOPENTANOATE-2-14C
UNII 9LYL8CRR6L
Substance Identification & Data
This profile provides standardized clinical and technical data for 4-nitrobenzyl (r)-2-diazo-4-((2r,3s)-3-((r)-1-hydroxyethyl)-4-oxoazetidin-2-yl)-3-oxopentanoate-2-14c, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 9LYL8CRR6L.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 137391-68-5 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
C17H18N4O7 FDXUXRZSNNSUGD-IVDJOYJUSA-N Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for 4-nitrobenzyl (r)-2-diazo-4-((2r,3s)-3-((r)-1-hydroxyethyl)-4-oxoazetidin-2-yl)-3-oxopentanoate-2-14c. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.